No Data
No Data
AEON Biopharma, Inc. (AEON) Loses -79.2% in 4 Weeks, Here's Why a Trend Reversal May Be Around the Corner
Express News | AEON Biopharma Provides Update on Development Pipeline
Express News | HC Wainwright & Co. Reiterates Buy on AEON Biopharma, Maintains $18 Price Target
AEON Biopharma Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/06/2024 990.91% HC Wainwright & Co. → $18 Reiterates Buy → Buy 04/17/2024 990.91% HC Wainwright & Co. →
Maintaining Buy on AEON Biopharma: Potential of ABP-450 Despite Phase 2 Setback
US Equity Markets Close Higher Friday Following Weak Jobs Report
US equity markets ended higher Friday after a weak jobs report raised bets on interest rate cuts. * Nonfarm payrolls rose by 175,000 in April, well below expectations for an increase of 240,000 jobs,
No Data
70927684 : What Happen???
BSDLuckyOP 70927684: Their trial candidate failed.
70927684 : LFG!!! Historical Low Play !!! Hornahha !!!!
70927684 : DP IT!!!
70927684 : LFG!!!!!!!!!!!!!!!!
View more comments...